These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7317951)

  • 21. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionation of immune RNA capable of transferring tumor-specific cellular cytotoxicity.
    Wang BS; Mannick JA
    Cell Immunol; 1978 May; 37(2):358-68. PubMed ID: 657284
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of protein synthesis in the activation of cytotoxic mouse macrophages by lymphokines.
    Blasi E; Varesio L
    Cell Immunol; 1984 Apr; 85(1):15-24. PubMed ID: 6713540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
    Nelson BJ; Ralph P; Green SJ; Nacy CA
    J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancy in the abilities of lymphokines and bacteria to mediate tumor protection in vivo and/or tumoricidal activity by macrophages in vitro.
    Keller R; Keist R; Schwendener RA
    Int J Cancer; 1989 Sep; 44(3):512-7. PubMed ID: 2506137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphokines of T and B cells. I. Demonstration that T and B cells of tumor antigensensitised mice produce different lymphokines changing surface charge of target cells.
    Jenssen HL; Eckert R; Werner H; Köhler H; Pasternak G; Friemel H
    Oncology; 1977; 34(4):159-63. PubMed ID: 303341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-induced changes in established tumor immunity.
    Vaage J; Doroshow JH; DuBois TT
    Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic aspects of macrophage activation for tumor cytotoxicity.
    Boraschi D
    Adv Exp Med Biol; 1982; 141():119-28. PubMed ID: 7046393
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice.
    Oguchi Y; Ando T; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Anticancer Res; 1987; 7(4B):681-4. PubMed ID: 3499859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
    Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
    J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic activity of the delta-endotoxin of Bacillus thuringiensis var thuringiensis (Berliner) on fibrosarcoma in Swiss mice.
    Rao AS; Amonkar SV; Phondke GP
    Indian J Exp Biol; 1979 Nov; 17(11):1208-12. PubMed ID: 549845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.